ClinicalTrials.Veeva

Menu

Non-invasive Transcranial Focused Low-intensity Ultrasound Stimulation in Patients With Mild Lewy Body Dementia (tFUS in DLB)

Capital Medical University logo

Capital Medical University

Status

Not yet enrolling

Conditions

Lewy Body Dementia

Treatments

Device: Transcranial low intensity focused ultrasound stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT05499429
[2022]110

Details and patient eligibility

About

A randomized controlled clinical study was conducted in the xuanwu hospital Single Center of Capital Medical University to preliminarily explore the efficacy and safety of transcranial focused low-intensity ultrasound stimulation in the treatment of dementia with Lewy bodies in the early stage, to clarify the effective mechanism and form an effective clinical treatment plan.

Full description

This project plans to recruit 20 patients with mild Lewy body dementia.They were randomly divided into transcranial focused low-intensity ultrasound active stimulation group and sham stimulation group. Patients receive treatment three days a week, and the daily treatment time is 20-30 minutes.The duration of treatment is 4-12 weeks. Before treatment, cognitive assessment, resting EEG, head MRI and PET examination of glucose metabolism were completed.Complete the overall cognitive assessment, resting EEG and MRI examination within one week after the treatment, and complete the overall cognitive assessment and PET examination of glucose metabolism at the follow-up 6 months after the treatment.Fill in the treatment side effect scale and adverse event form.Keep the original oral drug dosage unchanged during the treatment process.

Enrollment

20 estimated patients

Sex

All

Ages

50 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female DLB patients between the ages of 50-85;
  • The psychological evaluation was in accordance with MMSE score of 18-24 (including 18 and 24) and CDR score of 0.5.
  • Can cooperate to complete clinical research.

Exclusion criteria

  • There is a definite history of cerebrovascular stroke, and there are definite symptoms or signs of neurological deficit at the time of onset, and there are corresponding responsible lesions left by neuroimaging。
  • Those who have a history of alcoholism, or drug addiction, or neurological diseases such as brain trauma, epilepsy, encephalitis, normal intracranial pressure hydrocephalus, etc. that can cause cognitive impairment.
  • Suffering from systemic diseases that may lead to cognitive impairment (such as liver and kidney insufficiency, endocrine diseases, vitamin deficiency).
  • Have a history of using antipsychotics for more than five years before diagnosis.
  • There are contraindications for head MRI examination.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

20 participants in 2 patient groups

active stimulus group
Active Comparator group
Description:
Patients were assigned into active stimulus group according to random number table
Treatment:
Device: Transcranial low intensity focused ultrasound stimulation
sham stimulus control group
Sham Comparator group
Description:
Patients were assigned into sham stimulus control group according to random number table
Treatment:
Device: Transcranial low intensity focused ultrasound stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Penghu Wei, doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems